SOLV Solventum Corp

  1. Stocks
  2. Healthcare
  3. NYSE: SOLV

Price (delayed)

$82.42

Market cap

$14.27B

P/E Ratio

10.04

Dividend/share

N/A

EPS

$8.21

Enterprise value

$19B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 91

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental ...

Highlights
The company's equity has surged by 52% YoY
SOLV's price to earnings (P/E) is 36% lower than its last 4 quarters average of 14.9
The debt has decreased by 33% YoY but it has increased by 5% from the previous quarter
The quick ratio has declined by 21% since the previous quarter and by 19% year-on-year
The EPS has contracted by 8% from the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: https://www.solventum.com
Peers: TDOC VEEV OMCL

Key stats

What are the main financial stats of SOLV

SOLV stock price

How has the Solventum stock price performed over time
Intraday
5.18%
1 week
8.53%
1 month
22.21%
1 year
9.69%
YTD
4.01%
QTD
26.22%

Financial performance

How have Solventum's revenue and profit performed over time
Revenue
$8.26B
Gross profit
$4.43B
Operating income
$559M
Net income
$1.43B
Gross margin
53.7%
Net margin
17.3%
Solventum's operating income has decreased by 31% YoY and by 12% QoQ
The operating margin fell by 30% YoY and by 11% QoQ
Solventum's net income has decreased by 8% QoQ
The net margin has decreased by 7% from the previous quarter

Price vs fundamentals

How does SOLV's price correlate with its fundamentals

Growth

What is Solventum's growth rate over time

Valuation

What is Solventum stock price valuation
P/E
10.04
P/B
2.88
P/S
1.74
EV/EBIT
9.52
EV/EBITDA
7.63
EV/Sales
2.3
SOLV's price to earnings (P/E) is 36% lower than its last 4 quarters average of 14.9
The EPS has contracted by 8% from the previous quarter
The company's equity has surged by 52% YoY
The price to book (P/B) is 2.1% lower than the last 4 quarters average of 2.8
SOLV's price to sales (P/S) is 10% higher than its last 4 quarters average of 1.5

Efficiency

How efficient is Solventum business performance
The ROS has soared by 169% YoY but it has contracted by 2% from the previous quarter
Solventum's ROE has soared by 150% YoY but it has decreased by 16% from the previous quarter
Solventum's return on invested capital has increased by 10% QoQ
The company's return on assets fell by 7% QoQ

Dividends

What is SOLV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SOLV.

Financial health

How did Solventum financials performed over time
SOLV's total assets is 54% greater than its total liabilities
The quick ratio has declined by 21% since the previous quarter and by 19% year-on-year
The total liabilities fell by 19% YoY
The debt is 6% more than the equity
SOLV's debt to equity has shrunk by 56% YoY but it is up by 6% QoQ
The company's equity has surged by 52% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.